Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Alzheimer's Disease

Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm. 2009 Jul;116(7):905–11.
Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 2009 Jun;23(6):1643–54.
1alpha,25-dihydroxyvitamin D3 Interacts with Curcuminoids to Stimulate Amyloid-beta Clearance by Macrophages of Alzheimer's Disease Patients. J Alzheimers Dis. 2009 May 11.
Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies. Neuroscience. 2009 Feb 18;158(4):1478–87.
Gossypium herbaceam extracts attenuate ibotenic acid-induced excitotoxicity in rat hippocampus. J Alzheimers Dis. 2009 Feb;16(2):331–9.
Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008 Oct;65(10):1348–52.
Sarcopenia in nursing home residents. J Am Med Dir Assoc. 2008 Oct;9(8):545–51. Review.
A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study. J Am Geriatr Soc. 2008 Aug;56(8):1449–58.
Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil. 2008 Jul–Aug;10(4):315–23. Review.
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008 Apr;129(4):526–9.
Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25(6):539–43.
Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus. 2008;18(6):610–22.
Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med. 2007 Jul;212(3):275–82.
Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem. 2007 Apr;53(4):657–65.
Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006 Dec;14(12):1032–40.
Immobilization and hip fracture. Clin Calcium. 2006 Dec;16(12):1991–98. Review.
A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. Acta Neuropathol. 2006 Sep;112(3):267–76.
Oral zinc augmentation with vitamins A and D increases plasma zinc concentration: implications for burden of disease. Metab Brain Dis. 2006 Sep;21(2–3):139–47.
Expression of a familial Alzheimer's disease-linked presenilin-1 variant enhances perforant pathway lesion-induced neuronal loss in the entorhinal cortex. J Neurosci. 2006 Jan 11;26(2):429–34.
Toward prevention of Alzheimers disease—potential nutraceutical strategies for suppressing the production of amyloid beta peptides. Med Hypotheses. 2006;67(4):682–97.
Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Exp Neurol. 2005 Oct;195(2):484–96.
Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res. 2005 Aug;20(8):1327–33.
Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehabil. 2005 Mar;86(3):576–81.
Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone. 2005 Jan;36(1):61–8.
Risk factors for hip fracture among elderly patients with Alzheimer's disease. J Neurol Sci. 2004 Aug 30;223(2):107–12.
Alzheimer disease and calcium. Clin Calcium. 2004 Jan;14(1):103–5.
Chromogranin peptides in Alzheimer's disease. Exp Gerontol. 2004 Jan;39(1):101–13.
Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol. 2003 Aug;62(8):812–9.
Association of the 3' UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):114–7.
Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss. J Comp Neurol. 2003 Jan 6;455(2):249–59.
Genetics of menopause-associated diseases. Maturitas. 2001 Nov 30;40(2):103–16. Review.
The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease? Neurobiol Dis. 2001 Oct;8(5):900–9.
Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol. 2001 Oct;27(5):339–42.
Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease. Neuropathology. 2001 Sep;21(3):203–11.
Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology. 2001 Sep;21(3):162–7.
Parathyroid gland diseases and calcium metabolism disorders. Nippon Naika Gakkai Zasshi. 1999 Jul 10;88(7):1181–3.
Nucleus subputaminalis (Ayala): the still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area. Neuroscience. 1999 Mar;89(1):73–89.
Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease. Neuroscience. 1999;92(2):515–32.
High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone. 1998 Dec;23(6):555–7.
Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Exp Neurol. 1998 Aug;152(2):278–91.
Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Eur J Neurosci. 1998 Mar;10(3):1084–94.
Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy? J Clin Pharmacol. 1997 Dec;37(12):1087–99. Review.
The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease. Exp Neurol. 1997 May;145(1):295–302.
Calcium homeostasis in ageing: studies on the calcium binding protein calbindin D28K. J Neural Transm. 1997;104(10):1107–12.
Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res. 1995 Sep 11;691(1–2):83–91.
Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects. Brain Res Mol Brain Res. 1995 Jun;30(2):362–6.
Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience. 1994 Jun;60(3):621–36.
A subset of calretinin-positive neurons are abnormal in Alzheimer's disease. Acta Neuropathol. 1994;88(1):33–43.
The organotypic entorhinal-hippocampal complex slice culture of adolescent rats. A model to study transcellular changes in a circuit particularly vulnerable in neurodegenerative disorders. J Neural Transm Suppl. 1994;44:61–71.
Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study. Neurosci Lett. 1993 Dec 12;163(2):223–6.
Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci Lett. 1993 Apr 2;152(1–2):145–8.
Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Brain Res Mol Brain Res. 1993 Apr;18(1–2):32–42.
Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1993 Mar;56(3):257–61.
Differential incorporation of processes derived from different classes of neurons into senile plaques in Alzheimer's disease. Acta Neuropathol. 1993;86(4):365–70.
Calbindin D-28k immunoreactivity in the temporal neocortex in patients with Alzheimer's disease. Clin Neuropathol. 1993 Jan–Feb;12(1):53–8.
Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease. Dementia. 1993 Jan–Feb;4(1):1–15.
Vitamin D and aluminum absorption. CMAJ. 1992 Nov 1;147(9):1308, 1313.
Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res. 1992 Apr;13(3):239–50.
Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex. Cereb Cortex. 1992 Jan–Feb;2(1):56–67.
Phosphate/calcium alterations in the first stages of Alzheimer's disease: implications for etiology and pathogenesis. J Neurol Sci. 1991 Dec;106(2):221–9.
Nutritional intake in patients with senile dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 1991 Fall;5(3):173–80.
Calbindin-D-28k-like immunoreactive structures in the olfactory bulb and anterior olfactory nucleus of the human adult: distribution and cell typology—partial complementarity with parvalbumin. Neuroscience. 1991;42(3):823–40.
Reduced gastrointestinal absorption of calcium in dementia. Age Ageing. 1990 Nov;19(6):368–75.
Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4078–82.
Aluminum toxicity. Klin Wochenschr. 1989 Dec 15;67(24):1221–8. Review.
Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia. Brain Res. 1989 Oct 16;499(2):402–6.
Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res. 1988 Dec 13;475(1):156–9.
The aging of biological rhythms in man. Pathol Biol (Paris). 1987 Jun;35(6):1005–12.
Calmodulin and calbindin D28K in Alzheimer disease. Alzheimer Dis Assoc Disord. 1987;1(3):171–9.
Aging and calcium. Miner Electrolyte Metab. 1986;12(3):149–56. Review.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.